🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 4 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/07/1995 | 23,80 | 23,86 | 23,62 | 23,86 | +0,25% | 1,00% | 4.417.949 |
| 25/07/1995 | 23,86 | 23,91 | 23,68 | 23,80 | +0,00% | 1,00% | 3.494.661 |
| 24/07/1995 | 23,86 | 23,86 | 23,68 | 23,80 | -0,25% | 0,75% | 3.892.482 |
| 21/07/1995 | 23,74 | 23,91 | 23,62 | 23,86 | +0,50% | 1,26% | 8.285.488 |
| 20/07/1995 | 23,86 | 23,91 | 23,26 | 23,74 | -1,49% | 2,75% | 4.700.699 |
| 19/07/1995 | 24,03 | 24,39 | 23,44 | 24,09 | -0,49% | 3,97% | 8.384.210 |
| 18/07/1995 | 24,09 | 24,39 | 24,03 | 24,21 | +0,50% | 1,49% | 5.923.506 |
| 17/07/1995 | 24,15 | 24,21 | 24,03 | 24,09 | -0,25% | 0,74% | 3.088.456 |
| 14/07/1995 | 24,03 | 24,27 | 23,91 | 24,15 | -0,49% | 1,49% | 6.109.002 |
| 13/07/1995 | 23,74 | 24,33 | 23,20 | 24,27 | +2,78% | 4,77% | 10.000.645 |
| 12/07/1995 | 23,56 | 23,80 | 23,14 | 23,62 | +0,00% | 2,78% | 6.076.933 |
| 11/07/1995 | 23,32 | 23,74 | 23,26 | 23,62 | +1,02% | 2,05% | 5.816.819 |
| 10/07/1995 | 22,90 | 23,38 | 22,72 | 23,38 | +2,89% | 2,86% | 6.337.466 |
| 07/07/1995 | 23,08 | 23,14 | 22,54 | 22,72 | -2,31% | 2,58% | 9.031.664 |
| 06/07/1995 | 23,56 | 23,62 | 22,24 | 23,26 | -1,27% | 5,82% | 5.940.483 |
| 05/07/1995 | 23,74 | 23,86 | 23,50 | 23,56 | -0,50% | 1,51% | 4.888.082 |
| 03/07/1995 | 23,38 | 23,74 | 23,38 | 23,68 | +1,02% | 1,53% | 2.058.482 |
| 30/06/1995 | 23,86 | 23,91 | 23,38 | 23,44 | -1,26% | 2,25% | 2.615.179 |
| 29/06/1995 | 23,74 | 23,91 | 23,08 | 23,74 | +0,25% | 3,52% | 4.817.656 |
| 28/06/1995 | 23,08 | 23,80 | 23,08 | 23,68 | +2,06% | 3,10% | 4.765.046 |
| 27/06/1995 | 23,44 | 23,80 | 23,14 | 23,20 | -1,27% | 2,80% | 6.370.582 |
| 26/06/1995 | 23,74 | 23,80 | 23,44 | 23,50 | -1,01% | 1,51% | 3.772.800 |
| 23/06/1995 | 23,80 | 24,45 | 23,74 | 23,74 | -0,25% | 3,01% | 5.623.987 |
| 22/06/1995 | 23,50 | 23,86 | 23,32 | 23,80 | +1,53% | 2,28% | 8.243.987 |
| 21/06/1995 | 22,90 | 23,50 | 22,72 | 23,44 | +2,34% | 3,39% | 5.789.362 |
| 20/06/1995 | 23,20 | 23,26 | 22,72 | 22,90 | -1,03% | 2,31% | 4.103.968 |
| 19/06/1995 | 23,20 | 23,38 | 23,14 | 23,14 | -0,51% | 1,03% | 3.571.794 |
| 16/06/1995 | 23,14 | 23,26 | 23,02 | 23,26 | +0,78% | 1,03% | 8.142.750 |
| 15/06/1995 | 23,20 | 23,38 | 22,96 | 23,08 | +0,52% | 1,80% | 4.656.054 |
| 14/06/1995 | 23,02 | 23,08 | 22,54 | 22,96 | -0,52% | 2,33% | 2.999.586 |